| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A man with progressive type II respiratory failure
|
Hind, Matthew
|
|
2017
|
5 |
5 |
p. 456
|
artikel
|
| 2 |
Can India lead the way with the development of safer cookstoves?
|
Furlow, Bryant
|
|
2017
|
5 |
5 |
p. 386-387
|
artikel
|
| 3 |
Clinical trial research in focus: why do so many clinical trials fail in IPF?
|
Spagnolo, Paolo
|
|
2017
|
5 |
5 |
p. 372-374
|
artikel
|
| 4 |
Combined bevacizumab and erlotinib treatment in patients with lung cancer with the T790M resistance mutation
|
Mitsudomi, Tetsuya
|
|
2017
|
5 |
5 |
p. 369-370
|
artikel
|
| 5 |
Corrections
|
|
|
2017
|
5 |
5 |
p. e19
|
artikel
|
| 6 |
Economic effects and long-term prospects for Spain's respiratory health
|
Burki, Talha Khan
|
|
2017
|
5 |
5 |
p. 382-383
|
artikel
|
| 7 |
Effect of pest management on asthma symptoms
|
Kirby, Tony
|
|
2017
|
5 |
5 |
p. 380
|
artikel
|
| 8 |
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
|
Chupp, Geoffrey L
|
|
2017
|
5 |
5 |
p. 390-400
|
artikel
|
| 9 |
Engineering controls are the most protective means of controlling respirable coal mine dust
|
Blackley, David J
|
|
2017
|
5 |
5 |
p. e18
|
artikel
|
| 10 |
Environment-induced pulmonary oedema in healthy individuals
|
Marabotti, Claudio
|
|
2017
|
5 |
5 |
p. 374-376
|
artikel
|
| 11 |
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
|
Rosell, Rafael
|
|
2017
|
5 |
5 |
p. 435-444
|
artikel
|
| 12 |
Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe
|
Habre, Walid
|
|
2017
|
5 |
5 |
p. 412-425
|
artikel
|
| 13 |
Is hyperoxaemia a risk factor for ICU-acquired pneumonia?
|
Jaffal, Karim
|
|
2017
|
5 |
5 |
p. e16
|
artikel
|
| 14 |
Is hyperoxaemia a risk factor for ICU-acquired pneumonia? – Authors' reply
|
Asfar, Pierre
|
|
2017
|
5 |
5 |
p. e17
|
artikel
|
| 15 |
Managing asthma in the era of biological therapies
|
Bardin, Philip G
|
|
2017
|
5 |
5 |
p. 376-378
|
artikel
|
| 16 |
Marching for science
|
van Dorn, Aaron
|
|
2017
|
5 |
5 |
p. 389
|
artikel
|
| 17 |
Mepolizumab, quality of life, and severe eosinophilic asthma
|
Pavord, Ian D
|
|
2017
|
5 |
5 |
p. 362-363
|
artikel
|
| 18 |
Nosocomial nontuberculous mycobacteria infections associated with heater-cooler devices
|
Gilbert, Judith A
|
|
2017
|
5 |
5 |
p. 384
|
artikel
|
| 19 |
Occupational lung diseases: from old and novel exposures to effective preventive strategies
|
Cullinan, Paul
|
|
2017
|
5 |
5 |
p. 445-455
|
artikel
|
| 20 |
Plans to reduce the high asthma burden in Detroit
|
Nelson, Roxanne
|
|
2017
|
5 |
5 |
p. 388-389
|
artikel
|
| 21 |
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study
|
Çolak, Yunus
|
|
2017
|
5 |
5 |
p. 426-434
|
artikel
|
| 22 |
Pulmonary veno-occlusive disease as an occupational lung disease
|
Montani, David
|
|
2017
|
5 |
5 |
p. e19
|
artikel
|
| 23 |
Recreational cannabis legalisation in the USA outpaces research into health effects
|
Furlow, Bryant
|
|
2017
|
5 |
5 |
p. 385-386
|
artikel
|
| 24 |
Reducing diagnostic uncertainty to improve treatment of respiratory infections
|
Pavia, Andrew T
|
|
2017
|
5 |
5 |
p. 364-365
|
artikel
|
| 25 |
Respiratory diseases in the marginal labour sectors: a call to action
|
Moitra, Subhabrata
|
|
2017
|
5 |
5 |
p. 370-372
|
artikel
|
| 26 |
Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
|
Brendish, Nathan J
|
|
2017
|
5 |
5 |
p. 401-411
|
artikel
|
| 27 |
The economic cost of respiratory disease in the UK
|
Burki, Talha Khan
|
|
2017
|
5 |
5 |
p. 381
|
artikel
|
| 28 |
Time for a paradigm shift in paediatric anaesthesia in Europe
|
Lerman, Jerrold
|
|
2017
|
5 |
5 |
p. 365-367
|
artikel
|
| 29 |
Trump administration budget proposals “bad for health, science, environment, and America”
|
Furlow, Bryant
|
|
2017
|
5 |
5 |
p. 379-380
|
artikel
|
| 30 |
Underdiagnosis in COPD: a battle worth fighting
|
Almagro, Pere
|
|
2017
|
5 |
5 |
p. 367-368
|
artikel
|
| 31 |
US pollution policy up in the air
|
The Lancet Respiratory Medicine,
|
|
2017
|
5 |
5 |
p. 361
|
artikel
|
Tijdschrift beschrijving